The ELEVATE Study shows that atogepant effectively prevents episodic migraine.

Published Date: 24 Apr 2023

Atogepant (Qulipta) performed better than a placebo in the ELEVATE study for preventing episodic migraine in patients who were resistant to other treatments.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".

2.

Schizophrenia patients are motivated by music therapy.

3.

Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?

4.

Indoor hydroponic gardening can improve mental health and quality of life for cancer patients

5.

De-escalation Misses the Mark in Inflammatory Breast Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot